Compare Humana Inc (HUM) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Lucid Group Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Lucid Group Inc trades at $6.7 (market cap $2.60B). The key difference: Humana Inc is far larger — about 17.8× Lucid Group Inc's market cap, and Humana Inc pays a 0.92% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals.
| HUM | LCID | |
|---|---|---|
Market Cap | $46.31B | $2.60B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $24.77 |
52-Week Low | $163.67 | $4.62 |
Enterprise Value | $53.67B | $5.50B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Lucid Group (LCID) trades at $7.04, up 0.86% with a neutral technical signal despite recent earnings misses. The company reported Q2 2026 revenue of $405.3 million (beating estimates) but a wider loss of $3.30 per share due to inventory charges. Management is executing a $1.4 billion operational reset focusing on cost reductions, robotaxi partnerships, and delaying the Cosmos EV launch to 2027. Financial metrics show severe challenges with negative gross margins of -96.56% and net income margin of -249.21%.
The outlook remains high-risk with persistent cash burn and competitive pressures, though analyst consensus targets $10.50 representing 49% upside. Key risks include execution of the turnaround plan, EV market demand, and the need for future capital raises. The stock offers speculative potential if cost savings materialize but faces significant fundamental headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
